Summary:
MUMBAI: The 19-year-old multi-drug resistant TB patient from Patna who won a court battle for access to a newer TB drug, bedaquiline , died in a city hospital last month even though she was responding to the new treatment. But a one-size-fits-all programme is only likely to amplify the problem.”Dr Udwadia said India’s TB programme has to improve in many departments. The initial national TB programme was a disaster, under-funded and wasn’t working. “This girl had moved the Delhi high court when she was refused the drug by a Delhi hospital…She had a miserable end,” he said. All this optimistic talk of eradicating TB by 2030 and then by 2025 by the PM makes me amused and then angry,” he said..